Yetişir, A. E. Et Al. 2024. Association of systemic inflammatory markers with prognosis in erlotinib-treated EGFR-mutant non-small cell lung cancer. Journal of Cancer Research and Therapeutics , vol.20, no.1 , 285-288.

Yetişir, A. E., PAYDAŞ, S., Büyükşimşek, M., Oğul, A., Kolsuz, İ., & Kıdı, M. M., (2024). Association of systemic inflammatory markers with prognosis in erlotinib-treated EGFR-mutant non-small cell lung cancer. Journal of Cancer Research and Therapeutics , vol.20, no.1, 285-288.

Yetişir, ABDULLAH Et Al. "Association of systemic inflammatory markers with prognosis in erlotinib-treated EGFR-mutant non-small cell lung cancer," Journal of Cancer Research and Therapeutics , vol.20, no.1, 285-288, 2024

Yetişir, ABDULLAH E. Et Al. "Association of systemic inflammatory markers with prognosis in erlotinib-treated EGFR-mutant non-small cell lung cancer." Journal of Cancer Research and Therapeutics , vol.20, no.1, pp.285-288, 2024

Yetişir, A. E. Et Al. (2024) . "Association of systemic inflammatory markers with prognosis in erlotinib-treated EGFR-mutant non-small cell lung cancer." Journal of Cancer Research and Therapeutics , vol.20, no.1, pp.285-288.

@article{article, author={ABDULLAH EVREN YETİŞİR Et Al. }, title={Association of systemic inflammatory markers with prognosis in erlotinib-treated EGFR-mutant non-small cell lung cancer}, journal={Journal of Cancer Research and Therapeutics}, year=2024, pages={285-288} }